Running a clinical trial is a tremendous effort, requiring extensive resources. No company
wants to spend any more effort than required to get their product to market. A recent whitepaper published by ImageIQ talks discusses the application of preclinical study in clinical trials to help save time and money.
The paper starts by discussing the status of clinical trials, illustrating that current clinical trials have more procedures and less patient retention. In addition, many trials last longer, and have more stringent inclusion and exclusion criteria. Of course, this all leads to higher costs to conduct a study. With the statistics at hand, anyone wonders what they can do to improve the process. The whitepaper discusses six ways to streamline the design of the clinical trial by leveraging pre-clinical work, from translating protocols used for preclinical studies to your clinical trial to ensuring your preclinical data is robust.
IMARC Research and ImageIQ recently entered a partnership to leverage the skillsets of each company, and this whitepaper illustrates one way that ImageIQ can provide IMARC clients with their unique imaging and image analysis clinical trial expertise.
We recommend you give it a read and let us know your thoughts.
Photo Credit: 401(k) 2013
